Company profile
DelNova company profile
DelNova is developing proprietary therapies by leveraging advances in drug delivery technology. They have identified an anticholinesterase class of drugs as a means of accelerating muscle recovery by indirectly increasing the neurotransmitter deficit caused by botulinum toxin.
Business identity
- Website
- https://www.delnova.net
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Illinois City, Illinois, United States
- Postal code
- 60035
- Country code
- US
- Continent
- North America